|1.||Giménez-Llort, Lydia: 1 article (01/2011)|
|2.||Alonso, Eva: 1 article (01/2011)|
|3.||Vieytes, Mercedes R: 1 article (01/2011)|
|4.||Botana, Luis M: 1 article (01/2011)|
|5.||Laferla, Frank M: 1 article (01/2011)|
|6.||Vale, Carmen: 1 article (01/2011)|
|7.||Brimble, Margaret A: 1 article (09/2005)|
|8.||Mountfort, Doug: 1 article (09/2005)|
|9.||Dragunow, Michael: 1 article (09/2005)|
|10.||Beuzenberg, Veronica: 1 article (09/2005)|
09/01/2002 - "In contrast to earlier versions of the neuroblastoma assay, gymnodimine was not detected by this modified method."
09/01/2005 - "The effects of the shellfish toxin gymnodimine and its analogues (gymnodimine acetate, gymnodimine methyl carbonate and gymnodamine) on cellular viability were tested using the Neuro2a neuroblastoma cell line. "
|2.||Neurodegenerative Diseases (Neurodegenerative Disease)
|3.||Alzheimer Disease (Alzheimer's Disease)
01/01/2011 - "In this work, we evaluated the effect of long term exposure of cortical neurons to gymnodimine in the progress of Alzheimer disease (AD) pathology in vitro. "
01/01/2011 - "The cholinergic antagonist gymnodimine improves Aβ and tau neuropathology in an in vitro model of Alzheimer disease."
|1.||Cholinergic Antagonists (Anticholinergics)
|2.||methyl carbonate (dimethyl carbonate)